↓ Skip to main content

Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study

Overview of attention for article published in PLOS Medicine, December 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
22 news outlets
twitter
37 tweeters

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
Published in
PLOS Medicine, December 2019
DOI 10.1371/journal.pmed.1002998
Pubmed ID
Authors

Tom Callender, Mark Emberton, Steve Morris, Ros Eeles, Zsofia Kote-Jarai, Paul D. P. Pharoah, Nora Pashayan

Twitter Demographics

The data shown below were collected from the profiles of 37 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 24%
Student > Master 7 21%
Student > Bachelor 5 15%
Professor > Associate Professor 2 6%
Student > Doctoral Student 2 6%
Other 5 15%
Unknown 4 12%
Readers by discipline Count As %
Medicine and Dentistry 11 33%
Biochemistry, Genetics and Molecular Biology 5 15%
Economics, Econometrics and Finance 4 12%
Agricultural and Biological Sciences 3 9%
Computer Science 1 3%
Other 3 9%
Unknown 6 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 186. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 January 2020.
All research outputs
#100,520
of 15,883,255 outputs
Outputs from PLOS Medicine
#248
of 3,494 outputs
Outputs of similar age
#3,746
of 360,961 outputs
Outputs of similar age from PLOS Medicine
#2
of 15 outputs
Altmetric has tracked 15,883,255 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,494 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 64.2. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,961 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.